Revexepride is primarily investigated for its potential therapeutic applications in gastrointestinal disorders. It acts as a prokinetic agent, stimulating motility in the gastrointestinal tract, which makes it useful in conditions like gastroparesis and chronic constipation. By enhancing the movement of food through the digestive system, it helps alleviate symptoms such as bloating, nausea, and abdominal discomfort. Additionally, its mechanism of action targets specific serotonin receptors, making it a candidate for managing irritable bowel syndrome (IBS) with constipation. Research continues to explore its efficacy and safety in clinical settings for these applications.